JP5167499B2 - 光角膜切除における角膜組織の保護のためのピレノキシンの使用 - Google Patents

光角膜切除における角膜組織の保護のためのピレノキシンの使用 Download PDF

Info

Publication number
JP5167499B2
JP5167499B2 JP2000604833A JP2000604833A JP5167499B2 JP 5167499 B2 JP5167499 B2 JP 5167499B2 JP 2000604833 A JP2000604833 A JP 2000604833A JP 2000604833 A JP2000604833 A JP 2000604833A JP 5167499 B2 JP5167499 B2 JP 5167499B2
Authority
JP
Japan
Prior art keywords
pirenoxine
ophthalmology
corneal
agent according
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000604833A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002539153A (ja
JP2002539153A5 (enExample
Inventor
ボルドリニ、エンリコ
シウフィ、マリオ
Original Assignee
ファルミジェア ホールディング エス．アール．エル．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファルミジェア ホールディング エス．アール．エル． filed Critical ファルミジェア ホールディング エス．アール．エル．
Publication of JP2002539153A publication Critical patent/JP2002539153A/ja
Publication of JP2002539153A5 publication Critical patent/JP2002539153A5/ja
Application granted granted Critical
Publication of JP5167499B2 publication Critical patent/JP5167499B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP2000604833A 1999-03-17 2000-03-13 光角膜切除における角膜組織の保護のためのピレノキシンの使用 Expired - Fee Related JP5167499B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ITRM99A000166 1999-03-17
IT1999RM000166A IT1305306B1 (it) 1999-03-17 1999-03-17 Uso della pirenoxina per la protezione dei tessuti corneali ininterventi di fotocheratectomia.
IT99A000166 1999-03-17
PCT/IT2000/000081 WO2000054757A2 (en) 1999-03-17 2000-03-13 Use of pirenoxine for the protection of corneal tissues in photokeratectomy

Publications (3)

Publication Number Publication Date
JP2002539153A JP2002539153A (ja) 2002-11-19
JP2002539153A5 JP2002539153A5 (enExample) 2007-01-25
JP5167499B2 true JP5167499B2 (ja) 2013-03-21

Family

ID=11406570

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000604833A Expired - Fee Related JP5167499B2 (ja) 1999-03-17 2000-03-13 光角膜切除における角膜組織の保護のためのピレノキシンの使用

Country Status (10)

Country Link
US (1) US6610686B1 (enExample)
EP (1) EP1173255B1 (enExample)
JP (1) JP5167499B2 (enExample)
AT (1) ATE349244T1 (enExample)
AU (1) AU3324100A (enExample)
DE (1) DE60032594T2 (enExample)
ES (1) ES2277831T3 (enExample)
IT (1) IT1305306B1 (enExample)
PT (1) PT1173255E (enExample)
WO (1) WO2000054757A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655002B2 (en) * 1996-03-21 2010-02-02 Second Sight Laser Technologies, Inc. Lenticular refractive surgery of presbyopia, other refractive errors, and cataract retardation
US9889043B2 (en) 2006-01-20 2018-02-13 Lensar, Inc. System and apparatus for delivering a laser beam to the lens of an eye
US10842675B2 (en) 2006-01-20 2020-11-24 Lensar, Inc. System and method for treating the structure of the human lens with a laser
US9545338B2 (en) 2006-01-20 2017-01-17 Lensar, Llc. System and method for improving the accommodative amplitude and increasing the refractive power of the human lens with a laser
US8500723B2 (en) 2008-07-25 2013-08-06 Lensar, Inc. Liquid filled index matching device for ophthalmic laser procedures
US8480659B2 (en) 2008-07-25 2013-07-09 Lensar, Inc. Method and system for removal and replacement of lens material from the lens of an eye
US8617146B2 (en) 2009-07-24 2013-12-31 Lensar, Inc. Laser system and method for correction of induced astigmatism
US8382745B2 (en) 2009-07-24 2013-02-26 Lensar, Inc. Laser system and method for astigmatic corrections in association with cataract treatment
US8758332B2 (en) 2009-07-24 2014-06-24 Lensar, Inc. Laser system and method for performing and sealing corneal incisions in the eye
CA2769097A1 (en) 2009-07-24 2011-01-27 Lensar, Inc. System and method for performing ladar assisted procedures on the lens of an eye
EP2456384B1 (en) 2009-07-24 2023-09-20 LENSAR, Inc. System for providing laser shot patterns to the lens of an eye
US8556425B2 (en) 2010-02-01 2013-10-15 Lensar, Inc. Purkinjie image-based alignment of suction ring in ophthalmic applications
CN103338692B (zh) 2010-10-15 2016-12-28 雷萨有限责任公司 眼睛内部的结构的扫描控制照明的系统和方法
USD695408S1 (en) 2010-10-15 2013-12-10 Lensar, Inc. Laser system for treatment of the eye
USD694890S1 (en) 2010-10-15 2013-12-03 Lensar, Inc. Laser system for treatment of the eye
US10463541B2 (en) 2011-03-25 2019-11-05 Lensar, Inc. System and method for correcting astigmatism using multiple paired arcuate laser generated corneal incisions
CA2858627C (en) * 2012-01-04 2020-12-01 Quark Pharmaceuticals, Inc. Double-stranded rna compounds to casp2 and uses thereof
CN103211754A (zh) * 2012-01-19 2013-07-24 武汉诺安药业有限公司 无菌稳定的吡诺克辛钠滴眼液的生产方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09510962A (ja) * 1994-01-21 1997-11-04 ジョナサン ジャビット 目の治療のためのシス−ハイドロキシプロリン類
WO1998053806A1 (en) * 1997-05-26 1998-12-03 New Vision Co., Ltd. Medicinal compositions for topical administration containing vitamin d and vitamin k
IT1292103B1 (it) * 1997-06-06 1999-01-25 Pharmaconsult S A S Composizioni farmaceutiche topiche contenenti pirfenossone e uso dello stesso nel trattamento di condizioni infiammatorie
EP1060748A4 (en) * 1998-02-25 2002-09-04 Wakamoto Pharma Co Ltd MEDICINES FOR CORNEAEPITHEL DISORDER

Also Published As

Publication number Publication date
EP1173255A2 (en) 2002-01-23
JP2002539153A (ja) 2002-11-19
EP1173255B1 (en) 2006-12-27
AU3324100A (en) 2000-10-04
WO2000054757A2 (en) 2000-09-21
ES2277831T3 (es) 2007-08-01
ATE349244T1 (de) 2007-01-15
ITRM990166A1 (it) 2000-09-17
WO2000054757A3 (en) 2001-03-29
IT1305306B1 (it) 2001-05-04
DE60032594D1 (de) 2007-02-08
US6610686B1 (en) 2003-08-26
DE60032594T2 (de) 2007-10-11
PT1173255E (pt) 2007-03-30

Similar Documents

Publication Publication Date Title
JP5167499B2 (ja) 光角膜切除における角膜組織の保護のためのピレノキシンの使用
US10925889B2 (en) Method of treating, reducing, or alleviating a medical condition in a patient
US5811446A (en) Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
David Waterbury et al. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium
US6248734B1 (en) Use of photodynamic therapy for prevention of secondary cataracts
Koay The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology
JP4615309B2 (ja) 白内障および他の眼球疾患の進行の改善
JP2007512352A (ja) 黄斑変性およびその他の眼科疾患の改善
JP2005104862A (ja) 加齢黄斑変性治療剤
JP3362501B2 (ja) 角膜障害治療剤
CA2429982C (en) Copper chelators for treating ocular inflammation
JP2007527417A (ja) 白内障、黄斑変性および他の眼疾患の改善
CN114126650B (zh) 尤其用于治疗角膜组织的液体制剂
JP4012575B2 (ja) 炎症の影響を低減するための組成物および物品
Malhotra et al. In vivo ocular availability of ketorolac following ocular instillations of aqueous, oil, and ointment formulations to normal corneas of rabbits: a technical note
RU2434633C2 (ru) Фармацевтические препаративные формы латрункулина
Bodaghi et al. Comparison of the efficacy and safety of two formulations of diclofenac sodium 0.1% eyedrops in controlling postoperative inflammation after cataract surgery
EP0950409B1 (en) Subepithelial turbidity inhibitor
EP4186524A1 (en) Prevention and/or treatment of eye disease by collagen fiber crosslinking
Jiang et al. Cyclic cell-penetrating peptide-engineered ceria nanoparticles for non-invasive alleviation of ultraviolet radiation-induced cataract
Russo et al. Topical nonsteroidal anti-inflammatory drugs in uncomplicated cataract surgery: effect of sodium naproxen
JPH10203979A (ja) チアプロフェン酸を含有する抗眼炎症剤
Ameen Prodrug approaches to ophthalmic drug delivery

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061129

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061129

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100622

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100922

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100930

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101022

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101029

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101119

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20101224

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111004

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111228

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120111

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120131

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120207

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120404

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121102

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20121203

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20121203

LAPS Cancellation because of no payment of annual fees